Sleep Research & Treatment Center, Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, PA.
Sleep Medicine Center, Shantou University Medical College, Shantou, China.
Sleep. 2019 Apr 1;42(4). doi: 10.1093/sleep/zsy265.
Mild-to-moderate obstructive sleep apnea (OSA) is highly prevalent in the general population; however, previous studies on its association with incident hypertension are mixed. We examined the association between mild and moderate OSA and incident hypertension in a large random general population sample.
From 1741 adults of the Penn State Cohort, 744 adults without hypertension or severe OSA (i.e. apnea/hypopnea index [AHI] ≥ 30 events/hour) were followed-up after 9.2 years. Mild OSA was defined as an AHI of 5 to 14.9 events/hour (n = 71), while moderate OSA as an AHI of 15 to 29.9 events/hour (n = 32). Incident hypertension was defined by a self-report of receiving antihypertensive medication and/or history of a diagnosis since their baseline study.
After adjusting for multiple potential confounders, mild-to-moderate OSA was significantly associated with increased risk of incident hypertension (overall hazard ratio [HR] = 2.94, 95% confidence interval (CI) = 1.96-4.41; HR = 3.24, 95% CI = 2.08-5.03 for mild OSA and HR = 2.23, 95% CI = 1.10-4.50 for moderate OSA). Importantly, this association was modified by age (p-interaction < 0.05); while strong in young and middle-aged adults (HR = 3.62, 95% CI = 2.34-5.60), the association was lost in adults older than 60 years (HR = 1.36 95% CI = 0.50-3.72). Furthermore, the association of mild-to-moderate OSA with components of metabolic syndrome was strongest in young and middle-aged adults.
Mild-to-moderate OSA, even when asymptomatic, is associated with increased risk of incident hypertension, but the strength of association significantly decreases with age. Although older participants with asymptomatic mild-to-moderate OSA are not at significant risk of developing hypertension, early detection and intervention, including improving metabolic indices, is especially warranted in young and middle-aged adults.
轻中度阻塞性睡眠呼吸暂停(OSA)在普通人群中发病率很高;然而,既往关于其与高血压发生的相关性研究结果不一。本研究旨在大规模随机一般人群样本中探讨轻中度 OSA 与新发高血压的相关性。
本研究纳入了宾夕法尼亚州队列的 1741 名成年人,其中 744 名成年人无高血压或严重 OSA(即呼吸暂停/低通气指数[AHI]≥30 次/小时),并在 9.2 年后进行随访。轻度 OSA 定义为 AHI 为 5 至 14.9 次/小时(n=71),中度 OSA 定义为 AHI 为 15 至 29.9 次/小时(n=32)。新发高血压定义为自基线研究以来报告接受降压药物治疗和/或有高血压诊断史。
在调整了多种潜在混杂因素后,轻中度 OSA 与新发高血压的风险增加显著相关(整体危险比[HR]为 2.94,95%置信区间[CI]为 1.96-4.41;HR 为 3.24,95%CI 为 2.08-5.03 为轻度 OSA,HR 为 2.23,95%CI 为 1.10-4.50 为中度 OSA)。重要的是,这种相关性受到年龄的影响(p 交互作用<0.05);在年轻和中年成年人中相关性较强(HR=3.62,95%CI=2.34-5.60),但在年龄大于 60 岁的成年人中则消失(HR=1.36,95%CI=0.50-3.72)。此外,在年轻和中年成年人中,轻中度 OSA 与代谢综合征各组分的相关性最强。
即使无症状,轻中度 OSA 也与新发高血压风险增加相关,但随着年龄的增长,相关性显著减弱。尽管无症状的轻中度 OSA 的老年参与者发生高血压的风险并不显著,但在年轻和中年成年人中,早期检测和干预(包括改善代谢指标)尤为重要。